100 related articles for article (PubMed ID: 1768043)
21. Comparison of DNA interstrand cross-linking and strand breakage by 1,3-bis(2-chloroethyl)-1-nitrosourea in polyamine-depleted and control human adenocarcinoma cells.
Seidenfeld J; Barnes D; Block AL; Erickson LC
Cancer Res; 1987 Sep; 47(17):4538-43. PubMed ID: 3113720
[TBL] [Abstract][Full Text] [Related]
22. Depletion of cellular glutathione by N,N'-bis(trans-4-hydroxycyclohexyl)-N'-nitrosourea as a determinant of sensitivity of K562 human leukemia cells to 4-hydroperoxycyclophosphamide.
Chresta CM; Crook TR; Souhami RL
Cancer Res; 1990 Jul; 50(13):4067-71. PubMed ID: 2354456
[TBL] [Abstract][Full Text] [Related]
23. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
[TBL] [Abstract][Full Text] [Related]
24. Compared cytotoxicity effects of five anticancer drugs on human (HBL) and mouse (B16) melanoma cells in vitro.
Arnould R; Dubois J; Abikhalil F; Libert A; Ghanem G; Atassi G; Hanocq M; Lejeune FJ
Anticancer Res; 1990; 10(3):789-93. PubMed ID: 2369092
[TBL] [Abstract][Full Text] [Related]
25. Glucocorticoid effect on melphalan cytotoxicity, cell-cycle position, cell size, and [3H]uridine incorporation in one of three human melanoma cell lines.
Benckhuijsen C; Osman AM; Hillebrand MJ; Smets LA
Cancer Res; 1987 Sep; 47(18):4814-20. PubMed ID: 3621177
[TBL] [Abstract][Full Text] [Related]
26. Prolidase, a potential enzyme target for melanoma: design of proline-containing dipeptide-like prodrugs.
Mittal S; Song X; Vig BS; Landowski CP; Kim I; Hilfinger JM; Amidon GL
Mol Pharm; 2005; 2(1):37-46. PubMed ID: 15804176
[TBL] [Abstract][Full Text] [Related]
27. Zinc-induced reduction in melphalan cytotoxicity: heterogeneity of response of cloned human tumor cells.
Tobey RA; Tesmer JG; Shackelford ME
J Cell Physiol; 1987 May; 131(2):235-9. PubMed ID: 3584249
[TBL] [Abstract][Full Text] [Related]
28. Augmentation of cisplatin (DDP) cytotoxicity in vivo by DL-buthionine sulfoximine (BSO) in DDP-sensitive and-resistant rat ovarian tumors and its relation to DNA interstrand cross links.
Chen G; Zeller WJ
Anticancer Res; 1991; 11(6):2231-7. PubMed ID: 1776864
[TBL] [Abstract][Full Text] [Related]
29. Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro.
Shellard SA; Hosking LK; Hill BT
Cancer Res; 1991 Sep; 51(17):4557-64. PubMed ID: 1873800
[TBL] [Abstract][Full Text] [Related]
30. Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity.
Fourie J; Guziec F; Guziec L; Monterrosa C; Fiterman DJ; Begleiter A
Cancer Chemother Pharmacol; 2004 Mar; 53(3):191-203. PubMed ID: 14614574
[TBL] [Abstract][Full Text] [Related]
31. In vivo and in vitro evaluation of the alkylating agent carmethizole.
Elliott WL; Fry DW; Anderson WK; Nelson JM; Hook KE; Hawkins PA; Leopold WR
Cancer Res; 1991 Sep; 51(17):4581-7. PubMed ID: 1873802
[TBL] [Abstract][Full Text] [Related]
32. Relationships among cell survival, O6-alkylguanine-DNA alkyltransferase activity, and reactivation of methylated adenovirus 5 and herpes simplex virus type 1 in human melanoma cell lines.
Maynard K; Parsons PG; Cerny T; Margison GP
Cancer Res; 1989 Sep; 49(17):4813-7. PubMed ID: 2547518
[TBL] [Abstract][Full Text] [Related]
33. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
Lai SL; Hwang J; Perng RP; Whang-Peng J
Oncol Res; 1995; 7(1):31-8. PubMed ID: 7549042
[TBL] [Abstract][Full Text] [Related]
34. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.
Green JA; Vistica DT; Young RC; Hamilton TC; Rogan AM; Ozols RF
Cancer Res; 1984 Nov; 44(11):5427-31. PubMed ID: 6488194
[TBL] [Abstract][Full Text] [Related]
35. Cellular resistance to chloroethylnitrosoureas, nitrogen mustard, and cis-diamminedichloroplatinum(II) in human glial-derived cell lines.
Aida T; Bodell WJ
Cancer Res; 1987 Mar; 47(5):1361-6. PubMed ID: 3469016
[TBL] [Abstract][Full Text] [Related]
36. Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation.
Belfi CA; Chatterjee S; Gosky DM; Berger SJ; Berger NA
Biochem Biophys Res Commun; 1999 Apr; 257(2):361-8. PubMed ID: 10198218
[TBL] [Abstract][Full Text] [Related]
37. [Tamoxifen increases cytotoxic effects of fotemustine. Experimental results on cell lines of human melanoma].
Fischel JL; Barbé V; Berlion M; Formento P; Berrile J; Bizzari JP; Milano G
Bull Cancer; 1994 Jul; 81(7):599-604. PubMed ID: 7742602
[TBL] [Abstract][Full Text] [Related]
38. DNA damage in cyclophosphamide-resistant tumor cells: the role of glutathione.
Richardson ME; Siemann DW
Cancer Res; 1995 Apr; 55(8):1691-5. PubMed ID: 7712476
[TBL] [Abstract][Full Text] [Related]
39. Increased sensitivity to cisplatin by nm23-transfected tumor cell lines.
Ferguson AW; Flatow U; MacDonald NJ; Larminat F; Bohr VA; Steeg PS
Cancer Res; 1996 Jul; 56(13):2931-5. PubMed ID: 8674043
[TBL] [Abstract][Full Text] [Related]
40. L-phenylalanine mustard (melphalan) uptake and cross-linking in the RPMI 6410 human lymphoblastoid cell line.
Brox LW; Gowans B; Belch A
Cancer Res; 1980 Apr; 40(4):1169-72. PubMed ID: 7357546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]